🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Allergic Conjunctivitis

Investigating Nasal and Ocular Immune Response to Conjunctival Allergen Exposure NCT07801625n/a1 site📍 Kingston Dr. Anne Ellis · Tests: Standardized Allergen Extract, Timothy Grass (Phleum pratense), Standardized Allergen Extract, Timothy Grass (Phleum pr… A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis NCT07169695Phase 211 sites📍 Kolkata📍 Ahmedabad📍 Ahmedabad Laboratoires Thea · Tests: Slit Lamp Examination, Far Best Corrected Visual Acuity (BCVA), T1695, Ciclosporin, Corneal fluorescein staining score … Daydrop® Triple Action for Allergic Eye Symptoms NCT07805759NA1 site📍 Madrid i+Med S.Coop. · Tests: Eye Drops, Lubricant Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis NCT06686472Phase 21 site📍 Memphis Telios Pharma, Inc. · Tests: TL-925, Placebo Treatment of Ocular Surface Inflammations NCT07732855n/a1 site📍 Budapest Semmelweis University · Tests: Topical Cyclosporine 1% Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms NCT07273747NA1 site📍 Kota Bharu Universiti Sains Malaysia · Tests: Kelulut Honey 60 g Oral Supplement, Kelulut Honey 120 g Oral Supplement, Honey-Flavoured Zero-Calorie Syrup (Placebo) 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis NCT06903884Phase 31 site📍 Hong Kong The University of Hong Kong · Tests: 3% Diquafosol ophthalmic solution and 0.1% Cyclosporin A cationic ophthalmic emulsion, 0.1% Cyclosporin A cationic opht… A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy NCT07675811Phase 31 site📍 Andover Regeneron Pharmaceuticals · Tests: REGN-2Cat, Freneslerbart, Mevonlerbart, Placebo Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface NCT04198740n/a2 sites📍 Montreal📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED NCT07519902Phase 377 sites📍 Huntington Beach📍 Laguna Hills📍 Loma Linda Dompé Farmaceutici S.p.A · Tests: Cenegermin, Vehicle Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis NCT07220408Phase 21 site📍 Smyrna Telios Pharma, Inc. · Tests: TL-925, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy